| 1.25 Data as of May 24 |  -0.02 / -1.57%Today’s Change | 0.62 Today|||52-Week Range 2.50 | -14.38% Year-to-Date |
| Previous close | 1.27 |
| Today’s open | 1.06 |
| Day’s range | 1.05 - 1.42 |
| Volume | 23,971 |
| Average volume (3 months) | 1,404 |
| Market cap | $12.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -86.25% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +4.26% |
| P/E ratio | 41.7 |
| Price/Sales | 0.09 |
| Price/Book | 0.19 |
| No competitors data available. |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $179.0M |
| Annual profit (last year) | $1.1M |
| Net profit margin | 0.60% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Chief Executive Officer Qing Tai Liu |
Chief Financial Officer & Director Yong Qiang Wang |
Corporate headquarters Changle, Shandong |
.
